DMPK / Exploratory Toxicology

ChemPartner’s Drug Metabolism Pharmacokinetic and Exploratory Toxicoly group (DMPK&Expl. Tox)consists of Bioanalytical (GLP and non-GLP), in vitro ADME, Pharmacokinetics and Toxicology groups. Our leadership team, drawing on Pharma experiences from world-renowned companies, emphasizes a science-based culture, and execution of quality DMPK/Toxicology studies as well as the integration of DMPK/Toxicology data into Pharma & Biotech partners’ discovery programs. ChemPartner also conducts studies for many Pharma and Biotech clients in support of their Regulatory Filings.

Since founded in 2007, extensive ADME profiling (>80,000) and PK& Exploratory Toxicology studies (>10,000) have been conducted to support numerous drug discovery and development programs with worldwide partners. Working closely with internal Biology, Pharmacology and Antibody Engineering teams, ChemPartner DMPK group supports translational medicine through our expertise in formulation development, in vitro-in vivo extrapolation, PK/PD modeling, biomarker analysis and metabolomics. We take pride in our work and view our partners’ success as our success.

Our Services:

• DMPK / Exploratory Toxicology
• Biomarkers, Preclinical & Clinical Sample Bioanalysis
• Large molecule PK/BA services